18. Dec 2024
In his third preclinical ion channel drug discovery blog, Marc Rogers explores the evolution of antibodies as ion channel modulators, highlighting breakthroughs in monoclonal antibodies, nanobodies, and antibody-toxin chimeras across immunology, cardiology, neuroscience, and oncology. Key case studies include Kv, Nav, Cav, TRP channels, and GPCR targets revealed through manual and automated patch clamp technologies.